2.4 mg semaglutide How Many Units Is of Semaglutide? Wegovy (Semaglutide) Weight Loss Injector 2.4 mg/0.75 mL is a prescription medication that contains the active ingredient semaglutide Sem-P™ - Getz Pharma -

Gilead Pipeline at a Glance Updated: May 21, 2026 Clinical stage programs* Opt-in Programs Phase 1 Phase 2 Phase 3 Therapeutic Areas Trial Phase x Understanding Pipeline Terms Phase 2 Phase 3 Opt-in Programs Phase 1 Phase 2 Phase 2 Phase 2 clinical trials study efficacy while also collecting data about safety

118 (11.7%) did not complete the trial In adults with established CVD either overweight or obesity, Safety data from the SELECT trial with Wegovy 2.4 mg Safety was evaluated in a trial of 17,604 patients 5 Safety data collection was limited to serious adverse events (including death), adverse events leading to discontinuation, and adverse events of special interest

It will take some time for your body to get used to the medication again

What happens if my shipment arrives and the contents are not cold

Supply challenges have affected GLP-1 medications in recent years, with significant shortages of semaglutide products driven by increased global demand